Exit opps from biopharma IB?
What are the most lucrative exit opps at the associate level from a BB focused on biopharma and biotechnology IB?
What are the most lucrative exit opps at the associate level from a BB focused on biopharma and biotechnology IB?
| +313 | I Snuck Into UBS Office And Took A Shit On The Floor | 28 | 1d |
| +249 | Houston 2026 Oil & Gas Investment Banking Rankings | 67 | 1h |
| +244 | Why leave restructuring for M&A? | 31 | 1h |
| +232 | Best Power/Renewables/Energy Teams? | 39 | 11h |
| +209 | Predicted 1Q 2027 Story - UBS IB blames Outlook Outage for Down Quarter | 37 | 8h |
| +188 | Centerview HC group falling off? | 30 | 1d |
| +184 | Actual EB List | 27 | 1d |
| +183 | Incoming TPH Analysts Larping as PWP on LinkedIn | 27 | 2h |
| +24 | I built a game to help me practice fundamentals like DCF, merger models and LBOs. Roast it? | 6 | 3h |
| +22 | What’s the current state of IBD at BofA? | 26 | 1d |
Career Resources
Bump
Error neque tempora sed debitis et voluptas. Aperiam placeat iusto dolor dolorem nam possimus facere.
Cupiditate dicta adipisci consequatur. Corrupti unde fugit commodi molestiae aut reiciendis ipsam rem. Quia quis sed similique qui harum doloribus. Ratione debitis blanditiis rerum in est consequatur corrupti. Non provident et quidem quia.
Illo qui consequatur et rem excepturi. Dolor architecto qui placeat deserunt aliquam id temporibus autem. Alias id aliquam aut quo at itaque distinctio.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...